Division of Biomedical Science, University of Nottingham Malaysia, Selangor, Malaysia.
University of Nottingham Malaysia, Selangor, Malaysia.
Am J Physiol Heart Circ Physiol. 2021 Apr 1;320(4):H1486-H1497. doi: 10.1152/ajpheart.00888.2020. Epub 2021 Feb 12.
MicroRNAs (miRNAs) are small regulatory molecules that are involved in posttranscriptional modifications. These noncoding RNAs are usually ferried by extracellular carriers such as exosomes or other protein and lipid carriers inside a range of body fluids including plasma and urine. Due to their ability to withstand harsh external conditions, exosomal miRNAs possess enormous potential as noninvasive disease biomarkers for, notably hypertension, whereby exosomal miRNAs have been implicated in its pathophysiological processes. More importantly, alterations in the microenvironment as a result of disease progression can induce active and selective loading of miRNAs into exosomes. In this paper, we first review the mechanisms of miRNA loading into exosomes, followed by the roles of exosomal miRNAs in the development of hypertension, and the potentials of exosomal miRNAs as biomarkers in comparison with other free circulating miRNAs. Finally, challenges and future research surrounding exosomal miRNAs will also be discussed. This review will aid in the understanding of noninvasive biomarkers for the early diagnosis of hypertension and for probing therapeutic efficacy.
微小 RNA(miRNA)是参与转录后修饰的小调控分子。这些非编码 RNA 通常由细胞外载体(如外泌体)或其他蛋白质和脂质载体携带,存在于多种体液中,包括血浆和尿液。由于其能够耐受恶劣的外部条件,外泌体 miRNA 作为非侵入性疾病生物标志物具有巨大的潜力,特别是在高血压中,外泌体 miRNA 已被牵连到其病理生理过程中。更重要的是,疾病进展导致的微环境改变可以诱导 miRNA 主动和选择性地装载到外泌体中。在本文中,我们首先综述了 miRNA 加载到外泌体的机制,然后讨论了外泌体 miRNA 在高血压发展中的作用,以及与其他游离循环 miRNA 相比,外泌体 miRNA 作为生物标志物的潜力。最后,还将讨论围绕外泌体 miRNA 的挑战和未来研究。这篇综述将有助于理解用于高血压早期诊断和探索治疗效果的非侵入性生物标志物。